Shenzhen Salubris Pharmaceuticals Co Ltd (002294)

Shenzhen

Currency in CNY

51.90

-1.19(-2.24%)

Closed·03:44:59

Fair Value

Unlock Value

Day's Range

51.79

53.12

52 wk Range

36.81

70.99

002294 Income Statement

Assess the Salubris Pharm A income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 002294 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2022

01/01

2023

01/01

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

3,058.39

3,482.01

3,365.34

4,012.23

4,352.66

Total Revenues Growth

aa.aa

+11.68%

+13.85%

-3.35%

+19.22%

+8.48%

Cost Of Revenues

aa.aa

811.29

1,000.77

1,065.46

1,138.06

1,105.08

Gross Profit

aa.aa

2,247.1

2,481.24

2,299.88

2,874.17

3,247.58

Gross Profit Growth

aa.aa

+18.85%

+10.42%

-7.31%

+24.97%

+12.99%

Gross Profit Margin %

aa.aa

73.47%

71.26%

68.34%

71.64%

74.61%

Other Operating Expenses, Total

aa.aa

1,742.8

1,915.67

1,734.06

2,190.35

2,607.11

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10%	+9.92%	-9.48%	+26.31%	+19.03%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	357.37	533.75	409.19	421.24	539.33
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,340.45	1,334.98	1,304.66	1,750.24	2,035.48
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	44.98	46.93	20.2	18.87	32.3

Operating Income

aa.aa

504.3

565.58

565.82

683.83

640.47

Operating Income Growth

aa.aa

+64.64%

+12.15%

+0.04%

+20.86%

-6.34%

EBIT Margin %

aa.aa

16.49%

16.24%

16.81%

17.04%

14.71%

Net Interest Expenses

aa.aa

171.37

138.72

63.57

63.92

84.25

Net Interest Expenses Growth

aa.aa

+855.67%

-19.05%

-54.17%

+0.55%

+31.81%

Interest Expense, Total

aa.aa

-10.53

-12.54

-17.37

-16.17

-21.69

Interest And Investment Income

aa.aa

181.9

151.26

80.94

80.09

105.94

Other Non Operating Expenses, Total

aa.aa

-13.32

-0.29

2.57

0.32

-11.18

EBT, Excl. Unusual Items

aa.aa

662.35

704

631.96

748.06

713.54

Gain (Loss) On Sale Of Assets

aa.aa

-1.3

-0.18

-0.48

-0.15

-3.03

Other Unusual Items, Total

aa.aa

-61.21

32.7

51.8

-129.91

-91.32

EBT, Incl. Unusual Items

aa.aa

599.84

713.73

641.76

632.52

655.91

EBT, Incl. Unusual Items Growth

aa.aa

+957.13%

+18.99%

-10.08%

-1.44%

+3.7%

EBT, Incl. Unusual Items Margin

aa.aa

19.61%

20.5%

19.07%

15.76%

15.07%

Income Tax Expense

aa.aa

71.52

79.36

60.93

27.36

3.12

Net Income to Company

aa.aa

528.32

634.37

580.83

605.16

652.78

Minority Interest

aa.aa

5.41

2.73

-0.76

-3.59

-1.28

Net Income

aa.aa

533.73

637.09

580.07

601.57

651.5

Net Income Growth

aa.aa

+776.9%

+19.37%

-8.95%

+3.71%

+8.3%

Net Income Margin %

aa.aa

17.45%

18.3%

17.24%

14.99%

14.97%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

533.73

637.09

580.07

601.57

651.5

Basic EPS - Continuing Operations

aa.aa

0.5

0.58

0.52

0.54

0.58

Basic EPS - Continuing Operations Growth

aa.aa

+733.33%

+16%

-10.34%

+3.85%

+7.41%

Diluted EPS - Continuing Operations

aa.aa

0.5

0.58

0.52

0.54

0.58

Diluted EPS - Continuing Operations Growth

aa.aa

+733.33%

+16%

-10.34%

+3.85%

+7.41%

Basic Weighted Average Shares Outstanding

aa.aa

1,067.45

1,098.43

1,115.51

1,114.02

1,123.28

Diluted Weighted Average Shares Outstanding

aa.aa

1,067.45

1,098.43

1,115.51

1,114.02

1,123.28

Dividend Per Share

aa.aa

0.4

0.5

0.55

Dividend Per Share Growth

aa.aa

+25%

+10%

EBITDA

aa.aa

798.4

873.67

893.22

1,046.33

1,028.9

EBITDA Growth

aa.aa

+44.55%

+9.43%

+2.24%

+17.14%

-1.67%

EBITDA Margin %

aa.aa

26.11%

25.09%

26.54%

26.08%

23.64%

EBIT

aa.aa

504.3

565.58

565.82

683.83

640.47

* In Millions of CNY (except for per share items)

FAQ

What was Salubris Pharm A’s revenue at year end?

At the end of the last reported fiscal year, Salubris Pharm A (002294) recorded total revenue of 4,352.66 million CNY.

How much revenue did Salubris Pharm A report in the most recent quarter?

In its most recent quarterly earnings report, Salubris Pharm A posted revenue of 1,228.44 million CNY.

What was Salubris Pharm A’s net income for the year?

For the full year, Salubris Pharm A reported net income of 651.50 million CNY.

How much net income did Salubris Pharm A post in the last quarter?

In the most recent quarter, Salubris Pharm A (002294) posted net income of 225.27 million CNY.

What was Salubris Pharm A’s gross profit for the year?

Gross profit for the year was reported at 3,247.58 million CNY.

How much gross profit did Salubris Pharm A generate last quarter?

Salubris Pharm A recorded gross profit of 940.77 million CNY in its latest quarterly report.

What was Salubris Pharm A’s annual operating income?

For the full year, Salubris Pharm A (002294) reported operating income of 640.47 million CNY.

What was Salubris Pharm A’s operating income last quarter?

Quarterly operating income was 246.41 million CNY.

What was Salubris Pharm A’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 343.52 million CNY.

What was the quarter-over-quarter change in EBITDA for Salubris Pharm A?

EBITDA changed by 153.55% million CNY compared to the last quarter.

What is Salubris Pharm A’s most recent gross profit margin?

The latest reported gross profit margin for Salubris Pharm A (002294) is 76.58% million CNY.

What is Salubris Pharm A’s most recent net income margin?

Net income margin based on recent financials is 18.34% million CNY.

What is Salubris Pharm A’s most recent EBIT margin?

Salubris Pharm A reported an EBIT margin of 20.06% million CNY based on current figures.

How did Salubris Pharm A’s revenue change compared to the previous quarter?

Revenue changed by 10.53% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Salubris Pharm A?

In the latest quarter, gross profit changed by 16.36% million CNY from the previous quarter.

S&P/TSX

33,457.28

-127.06

-0.38%

S&P/TSX 60

1,952.17

-6.82

-0.35%

US 30

48,996.60

-139.6

-0.28%

US 500

7,132.50

-6.3

-0.09%

S&P 500 VIX

18.10

+0.27

+1.51%

DAX

24,005.27

-35.02

-0.15%

Dollar Index

98.72

+0.244

+0.25%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	31.79	+1.34%	2.75M
ARC Resources	31.81	+0.86%	1.87M
Cenovus Energy Inc	38.74	+3.17%	1.36M
Canadian Natural	64.72	+2.02%	946.28K
RBC	242.78	-0.15%	694.72K
Canadian National Railway	150.09	-4.62%	343.56K
Celestica Inc.	494.25	+0.21%	88.99K

Name	Last	Chg. %	Vol.
Navco Pharmaceuticals	0.010	+100.00%	5.00K
NorthStar Gaming	0.02	+50.00%	21.00K
Vector Science Therapeutics	0.52	+40.54%	3.75K
Davidstea Inc	1.01	+26.25%	48.59K
Davidstea Inc	1.06	+29.27%	1.00K
Sparton Resources	0.0250	+25.00%	40.13K
Alset Capital	0.0250	+25.00%	326.08K

Name	Last	Chg. %	Vol.
Vendetta Mining	0.0050	-66.67%	1.53K
Bitterroot Resources	0.040	-27.27%	417.43K
Biomind Labs	0.15	-25.00%	900.00
Vision Lithium	0.0150	-25.00%	15.06K
Trans Canada Gold	0.1050	-25.00%	7.07K
FutureGen Industries	0.2700	-22.86%	17.90K
Mink Ventures	0.090	-18.18%	20.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	494.25	+0.21%	88.99K
TELUS	16.82	-0.18%	786.17K
Canadian Natural	64.72	+2.02%	946.28K
ARC Resources	31.79	+1.34%	2.75M
Air Canada	18.21	+0.94%	460.14K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaa Aaaaaaa	5.29	+65.58%	8.76
Aaaaaaaa Aa Aaaa	5.89	+56.25%	9.20
Aaaaaaaaaaaa	90.66	+53.66%	139.31
Aaaaa Aaaaaaaaa	10.63	+43.00%	15.20
A Aaaaaaa Aaaaaa	10.83	+42.37%	15.42
Aaa A Aaaaa Aaaa	23.24	+41.90%	32.98
Aaaaaaaaaaaaaaaaaa	3.59	+40.60%	5.05

Name	Last	Upside	Fair Value
Aaa Aaa Aaaaaaa	5.29	+65.58%	8.76
Aaaaaaaa Aa Aaaa	5.89	+56.25%	9.20
Aaaaaaaaaaaa	90.66	+53.66%	139.31
Aaaaa Aaaaaaaaa	10.63	+43.00%	15.20
A Aaaaaaa Aaaaaa	10.83	+42.37%	15.42
Aaa A Aaaaa Aaaa	23.24	+41.90%	32.98
Aaaaaaaaaaaaaaaaaa	3.59	+40.60%	5.05

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Shenzhen Salubris Pharmaceuticals Co Ltd (002294)

002294 Income Statement

FAQ

What was Salubris Pharm A’s revenue at year end?

How much revenue did Salubris Pharm A report in the most recent quarter?

What was Salubris Pharm A’s net income for the year?

How much net income did Salubris Pharm A post in the last quarter?

What was Salubris Pharm A’s gross profit for the year?

How much gross profit did Salubris Pharm A generate last quarter?

What was Salubris Pharm A’s annual operating income?

What was Salubris Pharm A’s operating income last quarter?

What was Salubris Pharm A’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Salubris Pharm A?

What is Salubris Pharm A’s most recent gross profit margin?

What is Salubris Pharm A’s most recent net income margin?

What is Salubris Pharm A’s most recent EBIT margin?

How did Salubris Pharm A’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Salubris Pharm A?

Trending Stocks